← FDA Drug Approvals (Drugs@FDA)

RIVASTIGMINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RANBAXY · Approved 2005-12-21

Drug application

FDA Application #

ANDA077363

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIVASTIGMINE

Generic name

Rivastigmine Tartrate

Active ingredients

RIVASTIGMINE TARTRATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

RANBAXY

First approval

2005-12-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown